GenScript Biotech Enters into Partnership with NSG Bio to Boost Biotech Innovation
Thursday, April 24, 2025
GenScript Biotech has entered a strategic partnership with NSG Bio, a leading biotech incubator based in Singapore.
The collaboration aims to support growth and innovation in the biotechnology sector.
Under this agreement, GenScript will offer exclusive discounted rates and technical support from its team of scientists to companies operating within NSG Bio. These services will make it easier for startups and biotech firms to access advanced technologies, helping them move more quickly from research to market.
NSG Bio, established in 2019, supports the development of innovative solutions in areas such as healthcare, biomedical sciences, agrifood, and industrial biotechnology. Its focus includes precision medicine, synthetic biology, AI-driven drug discovery, and nucleic acid technologies.
The incubator is home to Singapore’s largest shared biotech laboratory and office space, and it works closely with both local and international partners. Over 50 resident companies have already benefited from its resources and network.
It highlights a shared goal of building a strong and forward-looking biotech community in the region.
This new partnership is expected to strengthen Singapore’s biotechnology landscape by encouraging collaboration between experienced global service providers and emerging biotech companies.
Source: prnewswire.com
